Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity
  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search
  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search
  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

InVivoMAb Anti-Mouse B7-H3&CD3 epsilon Antibody (Iv0207)


View Antibody details

InVivoMAb Anti-Mouse B7-H4 Antibody (Iv0257)


View Antibody details

InVivoMAb Anti-Mouse BAFFR/TNFRSF13C Antibody (Iv0266)


View Antibody details

InVivoMAb Anti-Mouse CCR8 Antibody (Iv0255)


View Antibody details

InVivoMAb Anti-Mouse CCR8 Antibody (Iv0265)


View Antibody details

InVivoMAb Anti-Mouse CD154/CD40L/TNFSF5 Antibody (MR-1)


View Antibody details

InVivoMAb Anti-Mouse CD16/CD32 Antibody (Iv0016)


View Antibody details

InVivoMAb Anti-Mouse CD19 & CD3 epsilon Antibody (1D3 & 145-2C11)


View Antibody details

InVivoMAb Anti-Mouse CD19 & CD3 epsilon Antibody (Iv0224)


View Antibody details

InVivoMAb Anti-Mouse CD19 & CD8 Bispecific Antibody (SAA2742)


View Antibody details